Pinzani M, Rombouts K. Liver fibrosis: from the bench to clinical targets[J]. Digestive and Liver Disease, 2004, 36(4):562-563.
[2]
Chen M H, Chen J C, Tsai C C, et al. The role of TGF-beta1 and cytokines in the modulation of liver fibrosis by Sho-saiko-to in rat\'s bile duct ligated model[J]. Journal of Ethnopharmacol, 2005, 97(1):7-13.
[3]
Gorrell M. Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection[J]. Liver, 2002, 22(2):93-101.
[4]
李瑞麟, 马勇, 魏伟, 等.白芍总苷治疗四氯化碳致大鼠肝纤维化的作用与其影响肝星状细胞功能的关系[J].中国新药杂志, 2007(9):685-689. Li Ruilin, Ma Yong, Wei Wei, el at. Pharmacological effects of total glucosides from paeony root on CCl4-induced liver fibrosis and function of hepatic stellate cells[J]. Chinese Journal of New Drugs, 2007(9):685-689. (in Chinese)
[5]
吴摇丽.免疫细胞对肝纤维化发展的影响[J].中国药理学通报, 2010, 26(12):1557-1560. Wu Yaoli. Effect of immunocytes on the process of hepatic fibrosis[J]. Chinese Pharmacological Bulletin, 2010, 26(12):1557-1560.(in Chinese)
[6]
王晓昆, 唐瑛.肝纤维化动物模型研究进展[J].动物医学进展, 2007(3):95-98. Wang Xiaokun, Tang Ying. Progress on animal model of hepatic fibrosis[J]. Progress in Veternary Medicine, 2007(3):95-98. (in Chinese)
[7]
Rajamani Karthikeyan, Somasundaram S T, Manivasagam T, et al. Hepatoprotective activity of brown alga padina boergesenii against CCl4 induced oxidative damage in Wistar rats[J]. Asian Pacific Journal of Tropical Medicine, 2010(10):696-701.
崔红燕, 刘成海, 孙保木, 等.扶正化淤方对四氯化碳肝纤维化大鼠基膜型基质金属蛋白酶活性的影响[J].时珍国医国药, 2009, 20(8):2045-2047. Cui Hongyan, Liu Chenghai, Sun Baoben, et al. Effects of Fuzheng Huayu decoction on membrane-type matrix-metalloproteinases activty in CCl4 induced rat fibrotic liver[J]. Lishizhen Medicine and Materia Medica Research, 2009, 20(8):2045-2047.(in Chinese)
